IGC Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.

About IGC

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. 

CEO
Ram Mukunda
CEORam Mukunda
Employees
70
Employees70
Headquarters
Potomac, Maryland
HeadquartersPotomac, Maryland
Founded
2005
Founded2005
Employees
70
Employees70

IGC Key Statistics

Market cap
33.30M
Market cap33.30M
Price-Earnings ratio
-4.38
Price-Earnings ratio-4.38
Dividend yield
Dividend yield
Average volume
642.50K
Average volume642.50K
High today
$0.3698
High today$0.3698
Low today
$0.3441
Low today$0.3441
Open price
$0.35
Open price$0.35
Volume
434.56K
Volume434.56K
52 Week high
$0.48
52 Week high$0.48
52 Week low
$0.2525
52 Week low$0.2525

IGC News

TipRanks 3d
IGC Pharma reports Q1 EPS (2c) vs. (3c) last year

Reports revenue $328,000 vs. $272,000 last year. Ram Mukunda, CEO of IGC Pharma (IGC), commented, “We began fiscal 2026 with solid strategic momentum, advancing...

TipRanks 7d
Igc Pharma’s Risky Venture: Navigating Financial Instability Amid Bitcoin Investment Plans

Igc Pharma, Inc. (IGC) has disclosed a new risk, in the Debt & Financing category. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

People also own

Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.